Establishment Labs is a global medical technology company that manufactures and markets Motiva Implants, a line of silicone gel-filled breast implants sold in over 100 countries for aesthetic and reconstructive procedures. The company's implants incorporate proprietary safety features including optimized surface technology, electronic identification systems, and innovative gel formulations designed to reduce adverse events such as rupture and capsular contracture. Establishment Labs generates revenue by selling directly to physicians, hospitals, and clinics in key markets and through exclusive distributors worldwide, while competing on superior safety data, proprietary technologies, vertically integrated manufacturing in ISO-certified facilities, and a broad product portfolio supported by extensive physician education and patient financing programs.